HF1479 amends Minnesota’s provider tax law to change the pharmacy refund process from an annual refund to a quarterly refund. Under current law, a pharmacy may claim a refund against provider tax liability for amounts paid to a wholesale drug distributor on legend drugs delivered outside Minnesota. This bill keeps that basic refund structure but allows qualifying pharmacies to file refund claims on a quarterly schedule tied to when the drugs were delivered outside the state, rather than waiting until the end of the year.
The bill sets out specific filing windows for each quarter and retains the rule that a refund claim must be filed within one year after the end of the quarter in which the drugs were delivered. It also preserves the interest rule for approved refunds, with interest beginning 60 days after a claim is filed. The change applies prospectively to legend drugs delivered outside Minnesota after December 31, 2025.
Impact
The bill amends Minnesota Statutes 2024, section 295.54, subdivision 2, which governs pharmacy refunds under the state’s provider tax system. Its practical effect is to accelerate refund timing for pharmacies that qualify, potentially improving cash flow and reducing the lag between tax payment and refund receipt. It does not change the underlying tax base or the refund formula, but it does alter administration, filing timing, and refund processing for pharmacies and the Department of Revenue.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the measure appears to be a technical administrative change rather than a highly controversial policy proposal. The caption and language suggest a generally neutral or supportive intent: simplifying and speeding up refund claims for pharmacies subject to the provider tax. No formal opposition, amendments, or recorded vote history is available in the provided materials.
Contention
The main policy issue is timing: pharmacies benefit from earlier access to refunds, while the state may face more frequent administrative processing and potentially earlier cash outflows. Any contention would likely center on whether quarterly filing creates additional compliance burden or administrative complexity for pharmacies and the Department of Revenue, versus the benefit of improved liquidity for pharmacies. No specific opposing viewpoints are documented in the provided record.
Pharmacy-related license and registration renewal and application procedures modifications, inspection requirements for pharmacy licensure modifications, and fees establishment
Commissioner of Human Services establishment of a directed pharmacy dispensing payment to improve and maintain access to pharmaceutical services; appropriating money